インドコ レメディーズ リミテッド - 損益計算書 (TTM)

インドコ レメディーズ リミテッド
IN ˙ NSEI ˙ INE873D01024
₹207.00 ↓ -6.90 (-3.23%)
2026-06-05
株価
損益計算書 (TTM)

インドコ レメディーズ リミテッド 損益計算書は、一定期間における収益と費用の変化を示します。損益計算書のデータには、売上高、売上総利益、研究開発費 (R&D) 、販売費、一般管理費 (SG&A) 、営業利益、所得税、支払利息、営業外収益、1株当たり利益 (EPS) 、発行済株式数が含まれています。

1株当たりの単位を除き、すべての数値は1,000,000倍です。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
収益 13,524 14,110 14,368 15,408 15,622 16,084 16,496 16,686 16,869 17,356 17,958 18,173 18,223 17,732 17,243 16,649 16,713 17,251 17,599 18,453
変化 (%) 4.34 1.82 7.24 1.39 2.96 2.56 1.15 1.10 2.89 3.47 1.20 0.27 -2.69 -2.76 -3.45 0.38 3.22 2.02 4.85
収益の% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
売上原価 3,828 4,290 4,433 4,946 4,786 5,388 5,604 5,661 5,179 5,826 5,946 6,204 5,720 6,227 5,943 5,556 4,917 5,576 5,641 5,417
変化 (%) 12.06 3.34 11.58 -3.25 12.58 4.01 1.01 -8.51 12.49 2.05 4.35 -7.80 8.86 -4.56 -6.52 -11.50 13.41 1.16 -3.96
収益の% 28.30 30.40 30.85 32.10 30.63 33.50 33.97 33.92 30.70 33.57 33.11 34.14 31.39 35.12 34.46 33.37 29.42 32.32 32.05 29.36
営業総利益 9,696 9,821 9,935 10,461 10,836 10,696 10,892 11,025 11,690 11,530 12,012 11,969 12,503 11,506 11,301 11,094 11,797 11,675 11,958 13,036
変化 (%) 1.28 1.16 5.30 3.59 -1.30 1.83 1.23 6.03 -1.37 4.18 -0.36 4.46 -7.98 -1.78 -1.83 6.34 -1.03 2.43 9.01
収益の% 71.70 69.60 69.15 67.90 69.37 66.50 66.03 66.08 69.30 66.43 66.89 65.86 68.61 64.88 65.54 66.63 70.58 67.68 67.95 70.64
販管費 2,832 3,423 3,407 3,435 3,014 3,616 3,718 3,941 3,307 4,141 4,219 4,621 3,676 4,685 4,761 5,259 4,038 5,460 5,545 4,257
変化 (%) 20.87 -0.46 0.83 -12.27 19.97 2.82 6.02 -16.10 25.22 1.89 9.51 -20.43 27.44 1.62 10.45 -23.21 35.21 1.55 -23.23
収益の% 20.94 24.26 23.71 22.30 19.29 22.48 22.54 23.62 19.60 23.86 23.50 25.43 20.18 26.42 27.61 31.59 24.16 31.65 31.51 23.07
研究開発 660 716 714 746 764 738 766 810 866 936 979 972 980 875 820 760 730 795 792 795
変化 (%) 8.60 -0.35 4.55 2.30 -3.34 3.79 5.69 7.00 8.02 4.59 -0.75 0.84 -10.72 -6.30 -7.25 -3.99 8.96 -0.44 0.46
収益の% 4.88 5.08 4.97 4.84 4.89 4.59 4.64 4.85 5.14 5.39 5.45 5.35 5.38 4.93 4.75 4.57 4.37 4.61 4.50 4.31
運用コスト 11,630 11,980 12,128 12,901 13,272 13,658 14,164 14,517 14,815 15,509 16,175 16,639 16,909 16,794 16,858 16,788 17,183 17,720 17,906 18,300
変化 (%) 3.01 1.23 6.38 2.87 2.91 3.70 2.49 2.05 4.69 4.29 2.87 1.62 -0.68 0.38 -0.42 2.36 3.12 1.05 2.20
収益の% 85.99 84.90 84.41 83.73 84.95 84.92 85.86 87.00 87.82 89.36 90.07 91.56 92.79 94.71 97.76 100.83 102.81 102.72 101.74 99.17
営業利益 1,894 2,131 2,240 2,507 2,351 2,426 2,332 2,169 2,054 1,846 1,783 1,534 1,314 938 385 -139 -470 -469 -307 154
変化 (%) 12.49 5.13 11.90 -6.22 3.19 -3.85 -6.97 -5.31 -10.12 -3.42 -13.99 -14.32 -28.61 -58.91 -135.93 239.34 -0.23 -34.55 -150.02
収益の% 14.01 15.10 15.59 16.27 15.05 15.08 14.14 13.00 12.18 10.64 9.93 8.44 7.21 5.29 2.24 -0.83 -2.81 -2.72 -1.74 0.83
支払利息 -208 -167 -145 -165 -140 -185 -217 -238 -287 -303 -333 -349 -445 -533 -594 -620 -780 -806 -901 -1,222
変化 (%) -19.56 -13.30 13.73 -14.75 32.20 17.25 9.21 20.80 5.54 10.07 4.80 27.51 19.69 11.35 4.50 25.81 3.24 11.83 35.68
収益の% -1.53 -1.18 -1.01 -1.07 -0.90 -1.15 -1.32 -1.42 -1.70 -1.74 -1.86 -1.92 -2.44 -3.01 -3.44 -3.73 -4.67 -4.67 -5.12 -6.62
純利益 1,157 1,317 1,393 1,548 1,537 1,617 1,569 1,423 1,281 1,134 1,016 985 767 321 -107 -737 -1,122 -1,105 -1,139 -952
変化 (%) 13.86 5.80 11.09 -0.70 5.23 -3.00 -9.33 -9.97 -11.45 -10.44 -3.06 -22.10 -58.20 -133.25 591.72 52.11 -1.47 3.06 -16.45
収益の% 8.55 9.33 9.70 10.05 9.84 10.06 9.51 8.53 7.59 6.53 5.66 5.42 4.21 1.81 -0.62 -4.43 -6.71 -6.41 -6.47 -5.16

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
IN:532612 ₹207.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista